February 1, 1999Journal of Internal MedicineOpen Access

Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects

View Full Paper

Ask AI

Bookmark

Why the study?

What is the prevalence of metabolic syndrome in drug-treated hypertensive patients compared to control subjects?

Structured PICO

What is the prevalence of metabolic syndrome in drug-treated hypertensive patients compared to control subjects?

Population

1,200 subjects (600 treated male and female hypertensives aged 40-59 years and 600 age- and sex-matched controls) randomly selected from population registers in Oulu, Finland.

Outcome

Prevalence of the metabolic syndrome using ten different definitions

A high proportion of treated hypertensive patients have additional cardiovascular risk factors or metabolic syndrome, highlighting the need for comprehensive risk management.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Definition-dependent rates and high co-risk factor burden in hypertensives support careful evaluation; leaves open standardized criteria for prospective studies.

Cite This Study

Rantala et al. (1999) studied this question.

synapsesocial.com/papers/69f7e3456d1e8212df5a2d28 https://doi.org/10.1046/j.1365-2796.1999.00429.x

Topics

Hypertension management

View Full Paper

Ask AI

Bookmark

Implication

Definition-dependent rates and high co-risk factor burden in hypertensives support careful evaluation; leaves open standardized criteria for prospective studies.

Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects

Structured PICO

Discussion

Implication

Cite This Study

Topics

Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider